Latest Stoke City news from StokeonTrentLive as Mark Robins looks for a second successive victory - but Norwich City are ...

Bluebird bio went public in 2013, raising approximately $116m through its IPO. The company has developed three US Food and Drug Administration (FDA)-approved gene therapy products, including Zynteglo ...

Reaction to the Champions League last-16 draw, plus Premier League latest news & Europa League and Conference draws.

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

Sutton then reiterated his point about Celtic’s bench needing to be stronger before admitting disappointment that the Hoops ...

The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

Arne Slot’s Liverpool finished first in the 36-team league phase of the competition to qualify directly for this stage. Read ...

SOMERVILLE, Mass., February 21, 2025--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global ...

Kwak Noh-jung, chief executive officer (CEO) of SK hynix Inc., has emphasized the company's responsibility in South Korea's ...

Americans set a new standard for UCL goal-scoring and playing time, but the knockout playoff round was unkind to the player ...

They defeated last-16 opponents Benfica in a 5-4 thriller in Lisbon last month, while Bayern Munich (quarter-final) and ...